共 50 条
- [1] Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) [J]. LIVERS, 2023, 3 (04): : 597 - 617
- [4] Updates in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Children [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (05): : 583 - 591
- [5] Risk Factors for Advanced Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S561 - S561
- [7] LIVER FIBROSIS IN ASIANS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE [J]. HEPATOLOGY, 2021, 74 : 1022A - 1022A
- [10] The evil relationship between liver fibrosis and cardiovascular disease in metabolic dysfunction-associated fatty liver disease (MAFLD): Looking for the culprit [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (03):